First-in-Human Trial of New Immunotherapy Approach Shows Efficacy in Antibiotic Resistance – Business Wire (press release)
|
First-in-Human Trial of New Immunotherapy Approach Shows Efficacy in Antibiotic Resistance
Business Wire (press release) “This study provides the first clinical evidence showing the human polyclonal antibody therapeutic–produced from our natural DiversitAb immunotherapy platform–is safe, and provides an option for recalcitrant infection resistant bacteria where … |
